Trial site
Istituto Europeo di Oncologia s.r.l
- 220running trials
- 55closed trials
The trials here
What the 278 trials at this site are about, from their registry records.
- Conditions
- Lung cancer85 trials
- Metastatic breast cancer36 trials
- Ovarian cancer24 trials
- Colorectal cancer23 trials
- Prostate cancer19 trials
- Melanoma16 trials
- Pancreatic cancer14 trials
- Endometrial cancer13 trials
- Childhood cancers12 trials
- Gastric and oesophageal cancer12 trials
- Triple-negative breast cancer11 trials
- Bladder cancer10 trials
- and 19 more
- Phase
- Phase 3149 trials
- Phase 264 trials
- Phase 1/231 trials
- Phase 120 trials
- Phase 2/310 trials
- Phase 44 trials
- Status
- Recruiting121 trials
- Active, not recruiting59 trials
- Completed54 trials
- Not yet recruiting40 trials
- Suspended3 trials
- Terminated1 trial
- Lead sponsor
- AstraZeneca26 trials
- Merck Sharp & Dohme LLC13 trials
- AstraZeneca AB10 trials
- Pfizer10 trials
- Novartis Pharmaceuticals8 trials
- and 134 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Recruiting
A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
Recruiting
Recruiting
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Recruiting
Recruiting
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 220.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer46 recruiting
- Metastatic breast cancer22 recruiting
- Prostate cancer16 recruiting
- Colorectal cancer14 recruiting
- Ovarian cancer14 recruiting
- Endometrial cancer10 recruiting
- Pancreatic cancer9 recruiting
- Bladder cancer7 recruiting
- Childhood cancers7 recruiting
- Follicular lymphoma7 recruiting
- Hodgkin lymphoma7 recruiting
- Diffuse large B-cell lymphoma6 recruiting
- Gastric and oesophageal cancer6 recruiting
- Kidney cancer6 recruiting
- Liver and biliary tract cancer4 recruiting
- Melanoma4 recruiting
- Neuroendocrine tumours4 recruiting
- Triple-negative breast cancer4 recruiting
- Multiple myeloma3 recruiting
- Thyroid cancer3 recruiting
- Acute myeloid leukaemia2 recruiting
- Cervical cancer2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Head and neck cancer2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Brain metastases1 recruiting
- Glioblastoma1 recruiting
- Mesothelioma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations
Completed
A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
Active, not recruiting
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
Completed
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Active, not recruiting
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Terminated
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Completed
Neoadjuvant Nivolumab and chemotherapy in stage I-II triple negative breast cancer.
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Not yet recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
GEN1046 Safety Trial in Patients With Malignant Solid Tumors
Active, not recruiting
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
Completed
Active, not recruiting
Completed
Showing 50 of 55.
Site data: ClinicalTrials.govUpdated 19 Nov 2026